Although the revenue and EPS for AtriCure (ATRC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

AtriCure (ATRC) delivered earnings and revenue surprises of +500.00% and +1.39%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?